Surface Oncology, Inc. (CIK: 0001718108) EDGAR, Information, Filings... CompaniesBIO.Com

Surface Oncology, Inc.

Mailing address
50 HAMPSHIRE STREET, 8TH FLOOR, CAMBRIDGE, Delaware, 02139
Phone
617-714-4096
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Surface Oncology, Inc. (CIK: 0001718108) is an American company incorporated in the state of Massachusetts. Head office is located at 50 HAMPSHIRE STREET, 8TH FLOOR, CAMBRIDGE, Massachusetts, 02139. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Surface Oncology, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Adams Chandra	0001950700	Oct-27-2022	officer: Deputy GC
Brunn Carsten	0001760229	Jun-28-2022	director
Boni Theresa	0001917233	Mar-15-2022	officer: General Counsel
Hickey Benjamin	0001753055	Dec-09-2021	director
Torres Denice	0001820278	Jul-06-2021	director
ONEILL ALISON	0001283882	Apr-26-2021	officer: Chief Medical Officer
RATH HENRY C.	0001859736	Apr-26-2021	officer: Chief Business Officer
Atlas Venture Associates IX, LLC	0001671207	Dec-17-2020	10 percent owner
Atlas Venture Associates IX, L.P.	0001671208	Dec-17-2020	10 percent owner
Atlas Venture Fund IX, L.P.	0001671219	Dec-17-2020	10 percent owner
GRAYZEL DAVID S.	0001732786	Dec-17-2020	director
EcoR1 Capital, LLC	0001587114	May-19-2020	10 percent owner
Ibrahim Ramy	0001787662	Sep-17-2019	director
Dwyer Wendy	0001771182	Apr-01-2019	officer: Chief Business Officer
ROSS ROBERT W.	0001733077	Jan-04-2019	officer: Chief Medical Officer
FEES JESSICA	0001760391	Dec-14-2018	officer: See Remarks
Nogelo Liisa I	0001745297	Jul-23-2018	officer: General Counsel
Sigal Charles Elliott	0001661908	Jul-02-2018	director
FMR LLC	0000315066	Apr-18-2018	10 percent owner, other: See Remark 1
FIL Ltd	0000318989	Apr-18-2018	10 percent owner, other: See Remark 1
BARRIS PETER J	0001005561	Apr-18-2018	10 percent owner
NOVARTIS AG	0001114448	Apr-18-2018	10 percent owner
LYNCH DANIEL	0001177082	Apr-18-2018	director
BARRETT M JAMES	0001219855	Apr-18-2018	10 percent owner
MOTT DAVID M	0001219871	Apr-18-2018	10 percent owner
KERINS PATRICK J	0001235112	Apr-18-2018	10 percent owner
SANDELL SCOTT D	0001237289	Apr-18-2018	10 percent owner
BASKETT FOREST	0001277631	Apr-18-2018	10 percent owner
Viswanathan Ravi	0001479386	Apr-18-2018	10 percent owner
Palombella Vito J.	0001492805	Apr-18-2018	officer: Chief Scientific Officer
New Enterprise Associates 14, L.P.	0001544328	Apr-18-2018	10 percent owner
NEA Partners 14, L.P.	0001551531	Apr-18-2018	10 percent owner
NEA 14 GP, LTD	0001551532	Apr-18-2018	10 percent owner
Chappel Scott C	0001551615	Apr-18-2018	officer: Chief Technology Officer
Torres S. Edward	0001552293	Apr-18-2018	10 percent owner
Sonsini Peter W.	0001559807	Apr-18-2018	10 percent owner
Florence Anthony A. Jr.	0001559827	Apr-18-2018	10 percent owner
Lilly Ventures Fund I LLC	0001575852	Apr-18-2018	10 percent owner
Hall Steven Edward	0001602732	Apr-18-2018	10 percent owner
Stelzer Laurie	0001644348	Apr-18-2018	director
Shanafelt Armen	0001656151	Apr-18-2018	director, 10 percent owner
Goater Jeff	0001656435	Apr-18-2018	director, officer: Chief Executive Officer
Novartis Institutes for BioMedical Research, Inc.	0001673852	Apr-18-2018	10 percent owner
LV Management Group, LLC	0001681884	Apr-18-2018	10 percent owner
MCDONOUGH GEOFF	0001732701	Apr-18-2018	director
October 2017 Liquidating Trust	0001737174	Apr-18-2018	10 percent owner
Kearney Michael J	0001737627	Apr-18-2018	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Surface Oncology, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-23-236303 (34 Act) Size: 12 KB	Sep-18-2023	001-38459 231259891
EFFECT	Document	Acc-no: 9999999995-23-002629 (33 Act) Size: 1 KB	Sep-12-2023	333-258518 231251533
EFFECT	Document	Acc-no: 9999999995-23-002628 (33 Act) Size: 1 KB	Sep-12-2023	333-231144 231251531
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-231544 (33 Act) Size: 22 KB	Sep-08-2023	333-270381 231245383
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-231542 (33 Act) Size: 22 KB	Sep-08-2023	333-263207 231245369
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-231539 (33 Act) Size: 22 KB	Sep-08-2023	333-254023 231245363
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-231535 (33 Act) Size: 22 KB	Sep-08-2023	333-237044 231245357
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-231534 (33 Act) Size: 22 KB	Sep-08-2023	333-230129 231245351
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-231530 (33 Act) Size: 22 KB	Sep-08-2023	333-224403 231245338
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-23-231522 (33 Act) Size: 21 KB	Sep-08-2023	333-258518 231245305
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-23-231521 (33 Act) Size: 21 KB	Sep-08-2023	333-231144 231245293
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-048762 ( Act) Size: 9 KB	Sep-08-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-048761 ( Act) Size: 10 KB	Sep-08-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-048760 ( Act) Size: 8 KB	Sep-08-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-048765 ( Act) Size: 8 KB	Sep-08-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-048758 ( Act) Size: 5 KB	Sep-08-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-048764 ( Act) Size: 8 KB	Sep-08-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-048757 ( Act) Size: 8 KB	Sep-08-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-048755 ( Act) Size: 6 KB	Sep-08-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-048754 ( Act) Size: 8 KB	Sep-08-2023

Recent 20 filings. View all Surface Oncology, Inc. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Surface Oncology, Inc. overview
Surface Oncology, Inc. job
Surface Oncology, Inc. stock
Surface Oncology, Inc. ownership
Surface Oncology, Inc. CEO
Surface Oncology, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.